Ainara Mira-Iglesias
Overview
Explore the profile of Ainara Mira-Iglesias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
876
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nunes M, Chauvel C, Raboni S, Lopez-Labrador F, Andrew M, Badar N, et al.
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70091.
PMID: 40082217
Respiratory viruses represent a significant public health threat. There is the need for robust and coordinated surveillance to guide global health responses. Established in 2012, the Global Influenza Hospital Surveillance...
2.
Boudewijns B, Caini S, Riccio M, Nunes M, Chaves S, Andrew M, et al.
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70085.
PMID: 40045898
Background: This study aimed to establish a Severity Scale for influenza and other acute respiratory infections (ARI), requiring hospitalization, for surveillance and research purposes (the SevScale). Such a scale could...
3.
Wyndham-Thomas C, Newbern E, Mira-Iglesias A, Dwivedi A, Orrico Sanchez A, Anton A, et al.
J Infect Public Health
. 2025 Feb;
18(5):102700.
PMID: 40014936
Background: JCOVDEN (Ad26.COV2.S), a viral-vector vaccine, was granted conditional marketing authorisation in the European Union for the prevention of COVID-19 in early 2021. We present JCOVDEN single-dose vaccine effectiveness (VE)...
4.
Mira-Iglesias A, Lopez-Lacort M, Bricout H, Loiacono M, Carballido-Fernandez M, Mollar-Maseres J, et al.
Influenza Other Respir Viruses
. 2025 Feb;
19(2):e70069.
PMID: 39909969
Background: International Classification of Diseases (ICD) codes obtained from real-world data can be used to identify influenza cases for epidemiological research but, without validation, may introduce biases. The objective of...
5.
Urchueguia-Fornes A, Munoz-Quiles C, Mira-Iglesias A, Lopez-Lacort M, Mengual-Chulia B, Lopez-Labrador F, et al.
J Infect Dis
. 2025 Feb;
PMID: 39907319
Introduction: The impact of RSV in older adults is under-recognized, and the limited existing studies on the incidence of hospitalizations show great variability. This study aims to estimate the seasonal...
6.
de Munter L, Meeraus W, Dwivedi A, Mitratza M, Wyndham-Thomas C, Carty L, et al.
Eur J Public Health
. 2025 Jan;
PMID: 39836896
Marketing authorization holders of vaccines typically need to report brand-specific vaccine effectiveness (VE) to the regulatory authorities as part of their regulatory obligations. COVIDRIVE (now id. DRIVE) is a European...
7.
Nguyen J, Mitratza M, Volkman H, de Munter L, Tran T, Marques C, et al.
EClinicalMedicine
. 2024 Dec;
79:102995.
PMID: 39726669
Background: Prior studies have reported lower effectiveness of XBB.1.5-adapted vaccines against hospitalization related to the Omicron JN.1 variant than the XBB variant. This study evaluated the effectiveness and durability of...
8.
Bosch Castells V, Mira-Iglesias A, Lopez-Labrador F, Mengual-Chulia B, Carballido-Fernandez M, Tortajada-Girbes M, et al.
Viruses
. 2024 Oct;
16(10).
PMID: 39459854
Viral respiratory diseases place a heavy burden on the healthcare system, with children making up a significant portion of related hospitalizations. While comorbidities increase the risk of complications and poor...
9.
Shirreff G, Chaves S, Coudeville L, Mengual-Chulia B, Mira-Iglesias A, Puig-Barbera J, et al.
Influenza Other Respir Viruses
. 2024 Oct;
18(10):e70017.
PMID: 39439102
Background: Respiratory viruses are known to represent a high burden in winter, yet the seasonality of many viruses remains poorly understood. Better knowledge of co-circulation and interaction between viruses is...
10.
Lopez-Lacort M, Munoz-Quiles C, Mira-Iglesias A, Lopez-Labrador F, Garces-Sanchez M, Escribano-Lopez B, et al.
Pediatrics
. 2024 Oct;
155(1.
PMID: 39363387
Objectives: This study assesses the effectiveness of nirsevimab, a monoclonal antibody, in preventing medically attended respiratory syncytial virus-lower respiratory tract infections (RSV-LRTIs) in a large primary care network in Spain,...